Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)

As part of the FDA's Advancing Regulatory Science Initiative, the Office of Chief Scientist supports innovation to improve the development and evaluation of new, safe, and effective medical products for diagnosing, treating, and preventing conditions and diseases. This Funding Opportunity Announcement (FOA) will provide support for one or more Collaborating Centers of Excellence in Regulatory Science and Innovation (CERSI) in the national capitol region. The CERSI's will be established to foster an innovative and thematically coherent approach to advance the field of regulatory science (including laboratory, population, behavioral, and manufacturing sciences) and the Critical Path Initiative toward more effective and efficient product development and evaluation.